Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections

MLA

Matthias T. Heemskerk, et al. Repurposing Diphenylbutylpiperidine-Class Antipsychotic Drugs for Host-Directed Therapy of Mycobacterium Tuberculosis and Salmonella Enterica Infections. Oct. 2021. EBSCOhost, https://doi.org/10.1038/s41598-021-98980-z.

APA

Matthias T. Heemskerk, Cornelis J. Korbee, Louis Wilson, C. Carvalho dos Santos, Mariëlle C. Haks, Tom H. M. Ottenhoff, Karin Dijkman, Frank A. W. Verreck, S. Q. van Veen, I. F. Gordijn, Frank Vrieling, C. G. Engele, J. J. Esselink, & Kimberley V. Walburg. (2021). Repurposing diphenylbutylpiperidine-class antipsychotic drugs for host-directed therapy of Mycobacterium tuberculosis and Salmonella enterica infections. https://doi.org/10.1038/s41598-021-98980-z

Chicago

Matthias T. Heemskerk, Cornelis J. Korbee, Louis Wilson, C. Carvalho dos Santos, Mariëlle C. Haks, Tom H. M. Ottenhoff, Karin Dijkman, et al. 2021. “Repurposing Diphenylbutylpiperidine-Class Antipsychotic Drugs for Host-Directed Therapy of Mycobacterium Tuberculosis and Salmonella Enterica Infections,” October. doi:10.1038/s41598-021-98980-z.